Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Neurocrine Biosciences Total Assets 2010-2024 | NBIX

Neurocrine Biosciences total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Neurocrine Biosciences total assets for the quarter ending March 31, 2024 were $3.472B, a 47.15% increase year-over-year.
  • Neurocrine Biosciences total assets for 2023 were $3.251B, a 37.27% increase from 2022.
  • Neurocrine Biosciences total assets for 2022 were $2.369B, a 14.29% increase from 2021.
  • Neurocrine Biosciences total assets for 2021 were $2.073B, a 19.47% increase from 2020.
  
Neurocrine Biosciences Annual Total Assets
(Millions of US $)
2023 $3,251
2022 $2,369
2021 $2,073
2020 $1,735
2019 $1,306
2018 $993
2017 $818
2016 $365
2015 $475
2014 $243
2013 $155
2012 $196
2011 $138
2010 $144
2009 $71
Neurocrine Biosciences Quarterly Total Assets
(Millions of US $)
2024-03-31 $3,472
2023-12-31 $3,251
2023-09-30 $2,848
2023-06-30 $2,613
2023-03-31 $2,360
2022-12-31 $2,369
2022-09-30 $2,143
2022-06-30 $2,006
2022-03-31 $2,145
2021-12-31 $2,073
2021-09-30 $2,017
2021-06-30 $1,956
2021-03-31 $1,846
2020-12-31 $1,735
2020-09-30 $1,503
2020-06-30 $1,516
2020-03-31 $1,362
2019-12-31 $1,306
2019-09-30 $1,180
2019-06-30 $1,067
2019-03-31 $958
2018-12-31 $993
2018-09-30 $934
2018-06-30 $841
2018-03-31 $806
2017-12-31 $818
2017-09-30 $772
2017-06-30 $754
2017-03-31 $289
2016-12-31 $365
2016-09-30 $399
2016-06-30 $430
2016-03-31 $459
2015-12-31 $475
2015-09-30 $492
2015-06-30 $511
2015-03-31 $528
2014-12-31 $243
2014-09-30 $258
2014-06-30 $270
2014-03-31 $279
2013-12-31 $155
2013-09-30 $166
2013-06-30 $175
2013-03-31 $184
2012-12-31 $196
2012-09-30 $193
2012-06-30 $202
2012-03-31 $210
2011-12-31 $138
2011-09-30 $149
2011-06-30 $127
2011-03-31 $134
2010-12-31 $144
2010-09-30 $150
2010-06-30 $155
2010-03-31 $80
2009-12-31 $71
2009-09-30 $76
2009-06-30 $87
2009-03-31 $101
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $14.161B $1.887B
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.411B 31.00
Chugai Pharmaceutical (CHGCY) Japan $54.679B 24.44
Takeda Pharmaceutical (TAK) Japan $42.314B 6.86
Merck (MKGAF) Germany $20.967B 19.78
Astellas Pharma (ALPMY) Japan $18.169B 28.69
Sandoz Group AG (SDZNY) Switzerland $14.745B 0.00
Shionogi (SGIOY) Japan $14.115B 12.66
United Therapeutics (UTHR) United States $11.642B 12.41
Catalent (CTLT) United States $10.225B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.726B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.935B 7.62
Revolution Medicines (RVMD) United States $6.854B 0.00
Ionis Pharmaceuticals (IONS) United States $6.117B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Madrigal Pharmaceuticals (MDGL) United States $4.892B 0.00
Alpine Immune Sciences (ALPN) United States $4.235B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.717B 0.00
Summit Therapeutics (SMMT) United States $3.082B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.028B 0.00
Corcept Therapeutics (CORT) United States $2.553B 23.13
PTC Therapeutics (PTCT) United States $2.532B 0.00
Indivior (INDV) United States $2.475B 11.73
Dyne Therapeutics (DYN) United States $2.248B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.075B 11.86
Recursion Pharmaceuticals (RXRX) United States $2.074B 0.00
Ardelyx (ARDX) United States $2.040B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.948B 0.00
Evotec AG (EVO) Germany $1.868B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.820B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.737B 17.95
Avadel Pharmaceuticals (AVDL) Ireland $1.705B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.596B 27.93
Soleno Therapeutics (SLNO) United States $1.508B 0.00
Xencor (XNCR) United States $1.486B 0.00
4D Molecular Therapeutics (FDMT) United States $1.350B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.271B 11.94
Pacira BioSciences (PCRX) United States $1.266B 12.60
Collegium Pharmaceutical (COLL) United States $1.227B 7.55
Enliven Therapeutics (ELVN) United States $1.065B 0.00
Cronos Group (CRON) Canada $1.024B 0.00
Ocular Therapeutix (OCUL) United States $0.955B 0.00
Cassava Sciences (SAVA) United States $0.954B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.950B 0.00
ARS Pharmaceuticals (SPRY) United States $0.945B 0.00
Relay Therapeutics (RLAY) United States $0.932B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.918B 0.00
USANA Health Sciences (USNA) United States $0.876B 14.19
Sage Therapeutics (SAGE) United States $0.839B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.729B 0.00
Siga Technologies (SIGA) United States $0.722B 10.68
Silence Therapeutics (SLN) United Kingdom $0.658B 0.00
Savara (SVRA) United States $0.650B 0.00
Lyell Immunopharma (LYEL) United States $0.602B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.596B 0.00
Exscientia (EXAI) United Kingdom $0.565B 0.00
OmniAb (OABI) United States $0.547B 0.00
Verve Therapeutics (VERV) United States $0.538B 0.00
Altimmune (ALT) United States $0.518B 0.00
KalVista Pharmaceuticals (KALV) United States $0.512B 0.00
ProKidney (PROK) United States $0.505B 0.00
Larimar Therapeutics (LRMR) United States $0.495B 0.00
Korro Bio (KRRO) United States $0.467B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.459B 0.00
Lexeo Therapeutics (LXEO) United States $0.421B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.407B 0.00
Tourmaline Bio (TRML) United States $0.406B 0.00
Esperion Therapeutics (ESPR) United States $0.394B 0.00
Heron Therapeutics (HRTX) United States $0.393B 0.00
Harrow (HROW) United States $0.367B 0.00
Black Diamond Therapeutics (BDTX) United States $0.366B 0.00
Nature's Sunshine Products (NATR) United States $0.359B 20.06
Organogenesis (ORGO) United States $0.329B 62.25
Enanta Pharmaceuticals (ENTA) United States $0.321B 0.00
Aquestive Therapeutics (AQST) United States $0.320B 0.00
Bioventus (BVS) United States $0.314B 0.00
Fractyl Health (GUTS) United States $0.312B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.308B 0.00
ESSA Pharma (EPIX) Canada $0.304B 0.00
Nektar Therapeutics (NKTR) United States $0.288B 0.00
Nanobiotix S.A (NBTX) France $0.288B 0.00
Akebia Therapeutics (AKBA) United States $0.287B 0.00
Eliem Therapeutics (ELYM) United States $0.282B 0.00
Xeris Biopharma Holdings (XERS) United States $0.280B 0.00
Pyxis Oncology (PYXS) United States $0.258B 0.00
Foghorn Therapeutics (FHTX) United States $0.255B 0.00
Adherex Technologies (FENC) United States $0.252B 0.00
Aldeyra Therapeutics (ALDX) United States $0.247B 0.00
Lyra Therapeutics (LYRA) United States $0.246B 0.00
Metagenomi (MGX) United States $0.237B 0.00
Avita Medical (RCEL) United States $0.226B 0.00
Conduit Pharmaceuticals (CDT) United States $0.221B 0.00
Acrivon Therapeutics (ACRV) United States $0.217B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.210B 0.00
Zevra Therapeutics (ZVRA) United States $0.209B 0.00
Galectin Therapeutics (GALT) United States $0.207B 0.00
Century Therapeutics (IPSC) United States $0.196B 0.00
Telomir Pharmaceuticals (TELO) United States $0.184B 0.00
Profound Medical (PROF) Canada $0.180B 0.00
MediWound (MDWD) Israel $0.177B 0.00
Regulus Therapeutics (RGLS) United States $0.173B 0.00
Innate Pharma SA (IPHYF) France $0.171B 0.00
Prelude Therapeutics (PRLD) United States $0.162B 0.00
Achieve Life Sciences (ACHV) Canada $0.162B 0.00
Incannex Healthcare (IXHL) Australia $0.152B 0.00
CytoDyn (CYDY) United States $0.146B 0.00
Elite Pharmaceuticals (ELTP) United States $0.139B 12.98
Amylyx Pharmaceuticals (AMLX) United States $0.138B 2.90
Cardiol Therapeutics (CRDL) Canada $0.136B 0.00
Karyopharm Therapeutics (KPTI) United States $0.132B 0.00
VAXART, INC (VXRT) United States $0.129B 0.00
GlycoMimetics (GLYC) United States $0.118B 0.00
OptiNose (OPTN) United States $0.114B 0.00
FibroGen (FGEN) United States $0.113B 0.00
Citius Pharmaceuticals (CTXR) United States $0.112B 0.00
Relmada Therapeutics (RLMD) United States $0.111B 0.00
Inotiv (NOTV) United States $0.110B 0.00
PMV Pharmaceuticals (PMVP) United States $0.102B 0.00
Assertio Holdings (ASRT) United States $0.098B 7.92
Vivani Medical (VANI) United States $0.098B 0.00
ProPhase Labs (PRPH) United States $0.098B 0.00
Aclaris Therapeutics (ACRS) United States $0.097B 0.00
AlloVir (ALVR) United States $0.092B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.089B 0.00
Jaguar Animal Health (JAGX) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.083B 0.00
Tempest Therapeutics (TPST) United States $0.082B 0.00
Journey Medical (DERM) United States $0.074B 0.00
Champions Oncology (CSBR) United States $0.070B 0.00
Carisma Therapeutics (CARM) United States $0.067B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.99
Mural Oncology (MURA) Ireland $0.065B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
BioLineRx (BLRX) Israel $0.054B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Unicycive Therapeutics (UNCY) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.040B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
CASI Pharmaceuticals (CASI) China $0.037B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
DURECT (DRRX) United States $0.036B 0.00
JanOne (JAN) United States $0.034B 0.00
Protara Therapeutics (TARA) United States $0.033B 0.00
Surrozen (SRZN) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
Nutriband (NTRB) United States $0.027B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Lipocine (LPCN) United States $0.025B 0.00
PolyPid (PYPD) Israel $0.024B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 10.53
NRx Pharmaceuticals (NRXP) United States $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.022B 0.00
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.020B 1.03
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Talphera (TLPH) United States $0.017B 0.00
Indaptus Therapeutics (INDP) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Avalo Therapeutics (AVTX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Dominari Holdings (DOMH) United States $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Molecular Templates (MTEM) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Clever Leaves Holdings (CLVR) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.42
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 42.66